mitomycin has been researched along with aristolochic acid i in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Abramowicz, D; Decaestecker, C; Lemy, A; Muniz Martinez, MC; Nortier, J; Rorive, S; Roumeguere, T; Salmon, I; Vanherweghem, JL; Wissing, KM; Zlotta, A | 1 |
2 other study(ies) available for mitomycin and aristolochic acid i
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up.
Topics: Administration, Intravesical; Adult; Antibiotics, Antineoplastic; Aristolochic Acids; Carcinogens; Drugs, Chinese Herbal; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Kidney Transplantation; Mitomycin; Risk Assessment; Time Factors; Urinary Bladder Neoplasms | 2008 |